TABLE 2.
BEFORE TREATMENT | ONE MONTH AFTER TREATMENT | ONE YEAR AFTER TREATMENT | P | |||
---|---|---|---|---|---|---|
Type II | SL | Mean ± SD | 3.67 ± 0.58 | 1 ± 1 | 1.67 ± 0.58 | 0.06 |
Median (IQR) | 4 (3–4) | 1 (0–2) | 2 (1–2) | |||
J | Mean ± SD | 3.67 ± 0.58 | 1±1 | 1.33 ± 0.58 | 0.061 | |
Median (IQR) | 4 (3–4) | 1 (0–2) | 1 (1–2) | |||
FD | Mean ± SD | 2.33 ± 2.52 | 2 ± 2.65 | 2 ± 2.65 | 0.368 | |
Median (IQR) | 2 (0–5) | 1 (0–5) | 1 (0–5) | |||
HNL | Mean ± SD | 3 ± 1.73 | 2 ± 1.73 | 2.33 ± 2.31 | 0.097 | |
Median (IQR) | 2 (2–5) | 1 (1–4) | 1 (1–5) | |||
Type III | SL | Mean ± SD | 7.13 ± 1.13 | 3.63 ± 0.74 | 4.38 ± 1.06 | 0.001 |
Median (IQR) | 7.5 (6.25–8) | 3.5 (3–4) | 4.5 (3.25–5) | |||
J | Mean ± SD | 6.63 ± 1.19 | 3 ± 1.07 | 3.88 ± 1.25 | 0.001 | |
Median (IQR) | 7 (5.25–7.75) | 3 (2–3.75) | 4 (2.5–5) | |||
FD | Mean ± SD | 4.63 ± 0.92 | 3.75 ± 1.17 | 4.25 ± 1.17 | 0.005 | |
Median (IQR) | 4 (4–5.75) | 3 (3–4.75) | 4 (3.25–5.5) | |||
HNL | Mean ± SD | 4.38 ± 1.06 | 3.25 ± 0.89 | 4.13 ± 0.99 | 0.001 | |
Median (IQR) | 4 (4–5.5) | 3 (3–3.75) | 4 (3.25–4.75) | |||
Type IV | SL | Mean ± SD | 7.78 ± 0.97 | 4 ± 0.71 | 5.22 ± 0.67 | 0.0001 |
Median (IQR) | 8 (7–8.5) | 4 (3.5–4.5) | 5 (5–6) | |||
J | Mean ± SD | 7.89 ± 0.78 4 | 4 ± 1.12 | 5.11 ± 1.62 | 0.0001 | |
Median (IQR) | 8 (7–8.5) | 4 (3–5) | 5 (3.5–6) | |||
FD | Mean ± SD | 4.78 ± 1.86 | 3.78 ± 1.79 | 4.11 ± 2.03 | 0.002 | |
Median (IQR) | 4 (3.5–5.5) | 3 (3–4.5) | 4 (3–4.5) | |||
HNL | Mean ± SD | 4.89 ± 1.27 | 3.22 ± 1.48 | 4 ± 1.23 | 0.0001 | |
Median (IQR) | 5 (4–6) | 3 (2–4.5) | 4 (3–5) |